Amino Acid Length: 300 residues (human isoform)
Domains: RNA-binding domain; acidic C-terminal region enriched in glutamate/aspartate residues .
MAK16 ensures the docking of GTPBP4/NOG1 to pre-60S ribosomal particles, facilitating 60S subunit maturation. Key functional partners include:
| Interaction Partner | Role | Score |
|---|---|---|
| EBNA1BP2 | rRNA processing | 0.999 |
| WDR12 | 28S and 5.8S rRNA maturation | 0.998 |
| GTPBP4 | GTPase activity in 60S subunit assembly | 0.997 |
| RSL24D1 | Ribosome biogenesis | 0.997 |
MAK16’s RNA-binding activity is essential for the maturation of 5.8S and LSU-rRNA .
Intellectual Developmental Disorder, Autosomal Recessive 39: Linked to MAK16 mutations .
Non-Syndromic X-Linked Intellectual Disability 14: Implicated in neurodevelopmental deficits .
Pathogenicity in Protozoa: Homologs in Entamoeba histolytica correlate with amebic liver abscess development, though human pathogenicity mechanisms remain under study .
Tissue Distribution: Ubiquitous expression, with high levels in the brain, liver, and pancreas .
Cellular Expression: Localized to nucleoli (RNA processing hubs) and cytoplasm (ribosome assembly sites) .
Source: Escherichia coli
Purity: Proprietary chromatographic techniques
Formulation: Phosphate-buffered saline (pH 7.4) with 30% glycerol and 1 mM DTT .
Design: Three siRNA sequences targeting MAK16 mRNA
Applications: Gene silencing studies to explore MAK16’s role in ribosome biogenesis and disease pathways .
Conservation: MAK16 homologs in Caenorhabditis elegans and Schistosoma mansoni share functional domains, underscoring evolutionary importance in rRNA processing .
Structural Insights: Acidic C-terminal region may regulate phosphorylation-dependent interactions during ribosome assembly .
MAK16 (also known as MAK16L or RBM13) is a homolog of the S. cerevisiae MAK16 gene that enables RNA binding activity . The human gene (ID: 84549) encodes a protein with significant evolutionary conservation across multiple species, including mouse (67920), rat (306526), and numerous other mammals . This high degree of conservation suggests critical biological functions. MAK16 interacts extensively with components of the 60S ribosomal protein, indicating its potential involvement in ribosome biogenesis or function .
Several validated research tools are available for MAK16 expression analysis:
| Tool Type | Product Identifier | Applications | Species Reactivity |
|---|---|---|---|
| Antibody | HPA050574 | Immunofluorescence, immunohistochemistry, western blot | Human |
| Antibody | HPA044417 | Immunohistochemistry | Human |
| siRNA | Proprietary designs | Gene knockdown | Human |
| shRNA | Multiple validated collections | Gene knockdown | Human |
| esiRNA | EHU018681 | Gene knockdown | Human |
| esiRNA | EMU091511 | Gene knockdown | Mouse |
For comprehensive protein-protein interaction studies, researchers should employ combinatorial approaches including co-immunoprecipitation followed by mass spectrometry, proximity labeling techniques (BioID/APEX), and yeast two-hybrid screening to validate MAK16's interactome .
Recent proteomic research has identified anti-MAK16 autoantibodies as novel biomarkers for systemic lupus erythematosus (SLE). In a comprehensive two-phase study involving 125 SLE patients, 111 healthy volunteers, and 60 disease controls, anti-MAK16 autoantibodies showed significantly higher expression levels in SLE patients compared to both control groups . This represents one of several previously unreported autoantibodies discovered through human proteome microarray screening technology.
Researchers employing either proteome microarray or ELISA methodology can reliably detect anti-MAK16 autoantibodies:
ELISA Protocol for Anti-MAK16 Detection:
Coat 96-well plates with purified MAK16 protein
Add patient serum samples (dilution optimization required)
Add horseradish peroxidase-labeled anti-human IgG
The study validated consistent results between protein microarray and ELISA methods, confirming methodological reliability across platforms .
Anti-MAK16 demonstrates clinically meaningful diagnostic potential for SLE:
| Comparison | AUC (ROC Curve) | Statistical Significance | Study Sample Size |
|---|---|---|---|
| SLE vs. Healthy Volunteers | 0.698 | p < 0.05 | 294 SLE patients, 461 controls |
| SLE vs. Disease Controls | 0.671 | p < 0.05 | 294 SLE patients, 461 controls |
While anti-MAK16 alone shows moderate diagnostic potential, its optimal clinical utility was demonstrated in a multimarker panel. When combined with anti-RPLP2, anti-PARP1, and anti-RPL7A, the diagnostic model achieved superior performance with AUC values of 0.828-0.932 across different comparison groups .
When conducting MAK16 knockdown studies, multiple experimental approaches should be considered:
siRNA approach: Utilize commercially available pre-designed siRNAs based on the Rosetta Inpharmatics algorithm that specifically target MAK16 mRNA .
shRNA approach: For stable knockdown, researchers should select from validated shRNA collections, ideally testing 3-5 different constructs to identify optimal knockdown efficiency .
CRISPR-Cas9 methodology: While not specifically mentioned in the search results, this approach represents the gold standard for complete gene knockout studies.
For all approaches, researchers must include appropriate controls (scrambled sequences, empty vectors) and validate knockdown efficiency at both mRNA (qRT-PCR) and protein (western blot) levels before assessing functional outcomes.
Given MAK16's interaction with 60S ribosomal proteins , researchers investigating its role in ribosome biogenesis should employ:
Ribosome profiling: To analyze how MAK16 affects ribosome assembly and function.
Polysome profiling: To assess how MAK16 knockdown affects translational efficiency.
rRNA processing assays: To determine if MAK16 participates in pre-rRNA processing steps.
Nucleolar localization studies: Using the validated antibodies (HPA050574, HPA044417) to visualize MAK16's subcellular distribution.
These approaches should be conducted in both normal conditions and under ribosomal stress to fully characterize MAK16's dynamic functions.
AI integration presents significant opportunities for analyzing MAK16-related datasets, though current human-AI interaction frameworks remain limited by "simplistic collaboration paradigms" . Researchers should be aware that AI systems trained on biological data may inherit biases that influence interpretations of experimental results . To maximize AI utility while minimizing bias:
Train models on diverse datasets spanning multiple cell types and experimental conditions
Implement transparent algorithmic decision-making processes
Design truly interactive AI systems that facilitate bidirectional collaboration rather than one-way recommendations
When studying MAK16 autoantibodies in SLE, researchers must address several methodological challenges:
Cross-reactivity assessment: Test for epitope cross-reactivity with other ribosomal proteins given MAK16's interactions with 60S ribosomal components .
Temporal dynamics: Design longitudinal studies to determine whether anti-MAK16 antibodies appear early in disease progression or correlate with disease activity.
Cellular localization experiments: Investigate whether MAK16 relocalization occurs during apoptosis or cellular stress, potentially exposing normally sequestered epitopes.
Epitope mapping: Identify specific MAK16 regions recognized by autoantibodies using peptide array technology or hydrogen-deuterium exchange mass spectrometry.
These approaches would help distinguish whether anti-MAK16 represents a causative factor in disease pathogenesis or a secondary phenomenon.
The extensive conservation of MAK16 across species provides opportunities for evolutionary biology investigations:
| Species | Gene ID | Evolutionary Distance from Human |
|---|---|---|
| Human | 84549 | - |
| Mouse | 67920 | ~75 million years |
| Rat | 306526 | ~75 million years |
| Dog | 475593 | ~96 million years |
| Chicken | 426924 | ~312 million years |
| Zebrafish | 192312 | ~435 million years |
Researchers should perform comparative genomic analyses to identify both highly conserved domains (suggesting core functions) and divergent regions (indicating species-specific adaptations). Multi-species functional complementation studies would help determine the degree of functional conservation.
When encountering contradictory findings regarding MAK16 function, researchers should employ:
Cell type-specific analyses: Assess MAK16 function across diverse cell types, as its role may vary between proliferating and differentiated cells.
Conditional knockdown systems: Utilize inducible systems to distinguish between direct and compensatory effects of MAK16 depletion.
Proteomic interaction maps under different conditions: Compare MAK16 interactomes under various cellular states (proliferation, stress, differentiation).
Single-cell approaches: Implement single-cell RNA-seq and proteomics to detect cell-to-cell variability in MAK16 function that may explain seemingly contradictory population-level data.
These methodological approaches would help reconcile discrepant findings and build a more comprehensive understanding of MAK16's multifaceted biological roles.
Recombinant human MAK16 protein is typically expressed in E. coli and purified using conventional chromatography techniques . The protein is often tagged with a His-tag at the N-terminus to facilitate purification and detection . The amino acid sequence of the recombinant MAK16 protein includes the following residues:
MGSSHHHHHH SSGLVPRGSH MGSMQSDDVI WDTLGNKQFC SFKIRTKTQS FCRNEYSLTG LCNRSSCPLA NSQYATIKEE KGQCYLYMKV IERAAFPRRL WERVRLSKNY EKALEQIDEN LIYWPRFIRH KCKQRFTKIT QYLIRIRKLT LKRQRKLVPL SKKVERREKR REEKALIAAQ LDNAIEKELL ERLKQDTYGD IYNFPIHAFD KALEQQEAES DSSDTEEKDD DDDDEEDVGK REFVEDGEVD ESDISDFEDM DKLDASSDED QDGKSSSEEE EEKALSAKHK GKMPLRGPLQ RKRAYVEIEY EQETEPVAKA KTT
The predicted molecular mass of the recombinant MAK16 protein is approximately 37.8 kDa . However, the observed molecular weight may vary due to post-translational modifications and other experimental factors .
MAK16, also known as RNA-binding motif protein 13 (RBM13), is a member of the MAK16 family of proteins . Despite its name, RBM13 has not been shown to be an RNA-binding protein, and its exact function remains unknown . The MAK16 family is involved in the maintenance of killer protein 16, which plays a role in various cellular processes .
Recombinant human MAK16 protein is used in various research applications, including:
The recombinant human MAK16 protein is typically formulated in a buffer containing PBS (pH 7.4), 30% glycerol, and 1 mM DTT . It is shipped with polar packs and should be stored at 4°C for short-term use or aliquoted and stored at -20°C for long-term use . It is important to avoid repeated freeze-thaw cycles to maintain the protein’s stability and activity .